# Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin

> **NCT00239616** · PHASE2 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Iron Sucrose injection

## Key facts

- **NCT ID:** NCT00239616
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-05
- **Primary completion:** 2003-09-15
- **Final completion:** 2003-09-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239616, "Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00239616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*